Migalastat

Trade Name: 
Galafold
Manufacturer/Distributor: 
Amicus Therapeutics UK Ltd
Distributed by: Innomar Strategies
Classification: 
Various alimentary tract and metabolism products
ATC Class: 
A16AX14 - migalastat
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2017/08/30
Date Marketed in Canada (yyyy/mm/dd): 
2018/01/15
Presentation: 
Capsule: 123 mg. DIN: 02468042
Comments: 
For the long-term treatment of adults with a confirmed diagnosis of Fabry disease.